Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 10,990,000 | 10,216,000 | 10,171,000 | 9,818,000 | 9,584,000 |
| Cost of Goods | 2,936,000 | 2,648,000 | 3,013,000 | 3,034,000 | 2,497,000 |
| Gross Profit | 8,054,000 | 7,568,000 | 7,158,000 | 6,784,000 | 7,087,000 |
| Operating Expenses | 5,593,000 | 5,080,000 | 6,261,000 | 5,332,000 | 4,990,000 |
| Operating Income | 2,461,000 | 2,488,000 | 897,000 | 1,452,000 | 2,097,000 |
| Interest Expense | 61,000 | 57,000 | 61,000 | 66,000 | 57,000 |
| Other Income | 204,000 | 285,000 | 349,000 | 225,000 | 185,000 |
| Pre-tax Income | 2,604,000 | 2,716,000 | 1,185,000 | 1,611,000 | 2,225,000 |
| Income Tax | 338,000 | 408,000 | 254,000 | 37,000 | 282,000 |
| Net Income Continuous | 2,266,000 | 2,308,000 | 931,000 | 1,574,000 | 1,943,000 |
| Net Income Discontinuous | -6,000 | 15,000 | -18,000 | 5,294,000 | 73,000 |
| Minority Interests | 11,000 | 6,000 | 9,000 | 3,000 | 8,000 |
| Net Income | $2,249,000 | $2,317,000 | $904,000 | $6,865,000 | $2,008,000 |
| EPS Basic Total Ops | 0.99 | 1.02 | 0.40 | 2.97 | 0.86 |
| EPS Basic Continuous Ops | 0.99 | 1.02 | 0.41 | 0.68 | 0.83 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | -0.01 | 2.29 | 0.03 |
| EPS Diluted Total Ops | 0.98 | 1.02 | 0.40 | 2.96 | 0.85 |
| EPS Diluted Continuous Ops | 0.98 | 1.01 | 0.41 | 0.68 | 0.82 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.01 | -0.01 | 2.28 | 0.03 |
| EBITDA(a) | $3,085,000 | $3,122,000 | $897,000 | $2,405,000 | $2,677,000 |